ODI Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is July - June.

Millions SEK. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2019
Period Ending	Mar '26 Mar 6, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2020 - 2019
Market Capitalization	76	35	110	84	82	68	Upgrade
Market Cap Growth	18.63%	-68.34%	30.91%	1.85%	21.08%	-20.36%	Upgrade
Enterprise Value	71	33	104	80	73	52	Upgrade
Last Close Price	4.12	2.18	7.20	5.50	5.40	4.46	Upgrade
PS Ratio	3.77	11.07	4.92	600.26	262.63	-	Upgrade
PB Ratio	39.04	81.70	54.76	32.54	8.87	4.17	Upgrade
P/TBV Ratio	39.04	81.70	54.76	32.54	8.87	4.17	Upgrade
EV/Sales Ratio	3.53	10.43	4.65	573.75	233.92	-	Upgrade
EV/EBITDA Ratio	-	-	240.49	-	-	-	Upgrade
EV/EBIT Ratio	-	-	242.14	-	-	-	Upgrade
Net Debt / Equity Ratio	-2.46	-3.49	-1.32	-2.52	-0.79	-0.90	Upgrade
Net Debt / EBITDA Ratio	17.23	0.27	-6.13	0.95	1.02	3.70	Upgrade
Net Debt / FCF Ratio	6.95	0.45	0.69	1.27	1.00	2.41	Upgrade
Asset Turnover	2.42	0.37	2.18	0.02	0.02	-	Upgrade
Inventory Turnover	-	-	-	0.77	0.34	-	Upgrade
Quick Ratio	1.23	0.71	1.14	1.30	6.84	26.74	Upgrade
Current Ratio	1.24	0.86	1.20	1.46	8.49	29.00	Upgrade
Return on Equity (ROE)	-60.91%	-489.19%	-24.84%	-116.63%	-56.64%	-21.89%	Upgrade
Return on Assets (ROA)	-2.11%	-40.47%	2.62%	-45.57%	-32.91%	-13.13%	Upgrade
Return on Capital Employed (ROCE)	-14.40%	-1283.70%	21.40%	-264.80%	-77.80%	-24.30%	Upgrade
Earnings Yield	-0.96%	-17.10%	-0.52%	-8.24%	-8.81%	-5.87%	Upgrade
FCF Yield	-	-9.53%	-3.49%	-6.10%	-8.98%	-8.93%	Upgrade
Buyback Yield / Dilution	-29.48%	-21.82%	0.76%	-1.69%	1.52%	-11.10%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.